Table 1 Associations between serum CXCL10 levels and clinicopathological characteristics in CESC patients
Characteristics | n (%) | CXCL10 (pg/mL) Median (Interquartile range) | P |
|---|---|---|---|
Age (years) | |||
≤ 51 | 96 (50.79) | 79.18 (18.82–452.75) | 0.066 |
> 51 | 93 (49.21) | 88.16 (23.31–641.55) | |
Tumor size (cm) | |||
≤ 4 cm | 100 (52.91) | 82.41 (18.82–641.55) | 0.146 |
> 4 cm | 89 (47.09) | 86.67 (23.31–338.63) | |
Tumor stage | |||
I-IIa | 110 (58.20) | 77.37 (23.31–641.55) | 0.008 |
IIb-IV | 79 (41.80) | 95.82 (18.82–338.63) | |
Lymph node metastasis | |||
Yes | 30 (15.87) | 84.10 (18.82–641.55) | 0.487 |
No | 159 (84.13) | 103.09 (23.31–338.63) | |
Distant metastasis | |||
Yes | 9 (4.76) | 83.04 (18.82–641.55) | 0.125 |
No | 180 (95.24) | 145.90 (29.71–283.19) | |